AI Image
Study identifies antidepressants that get patients well and keep them well
Medical Xpress • • health
Key Points:
- An international study analyzed data from 115 clinical trials with over 30,000 participants to compare the short- and long-term effectiveness of 20 antidepressants, including fluoxetine as a reference.
- Findings indicate that certain antidepressants can maintain patients' well-being during long-term use, with escitalopram, agomelatine, and duloxetine showing superior sustained response compared to fluoxetine.
- Escitalopram, a commonly prescribed SSRI, emerged as the most effective for long-term treatment, while agomelatine and duloxetine also performed well despite some concerns like agomelatine’s risk of liver failure.
- The study may influence future treatment guidelines by highlighting the importance of selecting antidepressants based on their long-term efficacy, though individual treatment decisions should consider the balance of benefits and side effects.
- Researchers emphasize that medication choice should be personalized, aiming not only to achieve symptomatic improvement but also to sustain wellness over time.
